Answers are grounded in this paper and cite their sources.
We propose that increased coupling by gap junctions is part of satellite glial cell activation, and that augmented coupling contributes to the lowering of pain threshold in oxaliplatin- and taxol-treated mice. We further propose that gap junction blockers may have potential in treating chemotherapy-induced neuropathic pain.
No takes yet. Share an insight, caveat, or question.
Warwick et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: